Effect of catecholamines on cardiac metabolism.
D000273:Adipose Tissue / Q000201:enzymology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000494:Allosteric Regulation / Q000187:drug effects; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002395:Catecholamines / Q000494:pharmacology*; D003331:Coronary Vessels / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D004734:Energy Metabolism; D004837:Epinephrine / Q000494:pharmacology; D005947:Glucose / Q000096:biosynthesis; D006003:Glycogen / Q000378:metabolism; D006321:Heart / Q000187:drug effects / Q000502:physiology; D050356:Lipid Metabolism; D008099:Liver / Q000201:enzymology; D009124:Muscle Proteins / Q000378:metabolism; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism*; D009638:Norepinephrine / Q000494:pharmacology; D010101:Oxygen Consumption; D010710:Phosphates / Q000378:metabolism; D010750:Phosphoproteins / Q000378:metabolism; D010764:Phosphorylase Kinase / Q000378:metabolism; D006005:Phosphorylases / Q000378:metabolism; D011955:Receptors, Drug
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D009124:Muscle Proteins; D010710:Phosphates; D010750:Phosphoproteins; D011955:Receptors, Drug; D006003:Glycogen; D000242:Cyclic AMP; D006005:Phosphorylases; D010764:Phosphorylase Kinase; D005947:Glucose; D002118:Calcium; D009638:Norepinephrine; D004837:Epinephrine